SLC22A13

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SLC22A13 mutation is significantly associated with the RNA expression of many other genes, with 1,198 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SLC22A13-associated genes across cancer lineages are CIDECP1, C15orf61, and COL13A1. Each is linked with SLC22A13 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC22A13-to-partner and partner-to-SLC22A13 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CIDECP1 grouped by SLC22A13-low versus SLC22A13-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC22A13→partner) and Y-score (partner→SLC22A13) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECCIDECP1 →+0.399+2.053<.001.00532
UCECC15orf61 →+0.420+3.491.001.00232
UCECCOL13A1 →-0.704-3.692.004.00132
SKCMMIR3122 →+0.609+4.175.001<.00132
UCECAIMP1 →+0.401+3.375.005.00432
UCECH2AZ1 →+0.607+3.202.002<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,198 associations by consensus.

CIDECP1 by SLC22A13 expression — UCEC

Box plot of CIDECP1 in SLC22A13-low vs SLC22A13-high samples in UCEC.

Explore this box plot interactively →

Exploration